Clarity Pharmaceuticals Ltd (CLRPF)
OTCMKTS · Delayed Price · Currency is USD
2.845
+0.095 (3.45%)
Jul 31, 2025, 9:30 AM EDT
Satixfy Communications Market Cap
Clarity Pharmaceuticals has a market cap or net worth of $1.07 billion as of August 1, 2025. Its market cap has decreased by -15.73% in one year.
Market Cap
1.07B
Enterprise Value
998.62M
Revenue
6.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.85
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 278.91M to 1.07B, an increase of 283.77%. That is a compound annual growth rate of 40.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.07B | 29.29% |
| Dec 31, 2024 | 827.89M | 143.75% |
| Dec 29, 2023 | 339.64M | 94.39% |
| Dec 30, 2022 | 174.72M | 26.78% |
| Dec 31, 2021 | 137.82M | -50.59% |
| Aug 25, 2021 | 278.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| American Oncology Network | 408.39M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |